- WB
Supplier Data
Western blot - Anti-Enterovirus D68 VP1 antibody [HL1997] (AB308217)
Non-infected (–) and infected (+) RD whole cell extracts (30 μg) were separated by 12% SDS-PAGE, and the membrane was blotted with Enterovirus D68 VP1 antibody [HL1997] (ab308217) diluted at 1 : 1000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.
Lane 1:
Non-infected RD whole cell extracts at 30 µg
Lane 2:
Infected RD whole cell extracts at 30 µg
Secondary
All lanes:
HRP-conjugated anti-rabbit IgG antibody
false
- WB
Supplier Data
Western blot - Anti-Enterovirus D68 VP1 antibody [HL1997] (AB308217)
Non-transfected (–) and transfected (+) 293T whole cell extracts (30 μg) were separated by 12% SDS-PAGE, and the membrane was blotted with Enterovirus D68 VP1 antibody [HL1997] (ab308217) diluted at 1 : 1000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.
Lane 1:
Non-transfected 293T cell extracts at 30 µg
Lane 2:
DDDDK- tagged enterovirus D68 VP1 transfected 293T whole cell extracts at 30 µg
Lane 3:
DDDDK- tagged enterovirus 71 VP1 transfected 293T whole cell extracts at 30 µg
Secondary
All lanes:
HRP-conjugated anti-rabbit IgG antibody
false
- WB
Supplier Data
Western blot - Anti-Enterovirus D68 VP1 antibody [HL1997] (AB308217)
Non-infected (–) and infected (+) RD whole cell extracts (20 μg) were separated by 12% SDS-PAGE, and the membrane was blotted with Enterovirus D68 VP1 antibody [HL1997] (ab308217) diluted at 1 : 1000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.
Lane 1:
Non-infected RD whole cell extracts at 20 µg
Lane 2:
Enterovirus 71 C2 infected RD whole cell extracts at 20 µg
Lane 3:
Enterovirus D68 infected RD whole cell extracts at 20 µg
Lane 4:
Coxsackievirus A6 infected RD whole cell extracts at 20 µg
Secondary
All lanes:
HRP-conjugated anti-rabbit IgG antibody
false
- sELISA
Supplier Data
Sandwich ELISA - Anti-Enterovirus D68 VP1 antibody [HL1997] (AB308217)
Sandwich ELISA detection of recombinant full-length VP1 protein(s) derived from different strains of Enterovirus (D68; 71) using ab308217 as detection antibody (1 μg/mL).
- sELISA
Supplier Data
Sandwich ELISA - Anti-Enterovirus D68 VP1 antibody [HL1997] (AB308217)
Sandwich ELISA detection of recombinant full-length VP1 protein(s) derived from different strains of Enterovirus (D68; 71) using antibodies as below : Capture : ab308408 (5 μg/mL) Detection : ab308217 (1 μg/mL)
Reactivity data
Product details
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This protein enables the structural integrity and infectivity of the virus. Enterovirus VP1 is a part of the viral capsid a protein complex that also includes VP2 VP3 and VP4. These proteins collectively protect the viral RNA genome and are involved in mediating interactions with the host immune system. The conformational structure of VP1 is recognized by neutralizing antibodies making it a focus point for vaccine development and antiviral drugs. Its expression and conformation can influence the antigenicity and serotype specificity of enteroviruses.
Pathways
Several actions revolving around host-pathogen interactions involve Enterovirus VP1. It plays a pivotal role in the cell entry mechanism through endocytic pathways. VP1 interacts with proteins such as ICAM-1 or PSGL-1 which serves as receptors in the early stages of viral pathogenesis. Additionally during viral uncoating and RNA release VP1 undergoes structural rearrangements that are essential for subsequent steps in the viral lifecycle and involve complex pathways like the host cell defense mechanism.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com